National Research Corporation
Health
Performance
6.9
Risk
Sell
Buy
Curious about the Scores? Learn more.

National Research Corporation stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.01.2026
Trouble brewing. Volatility and pressure rising.
06.01.2026
Slight bounce. Could be noise – or a comeback brewing.
15.12.2025
Barely upright. Still chaotic, but slowly finding some balance.
20.08.2025
Climbing out. Risks fading, but not out of the woods.

National Research Corporation stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does National Research Corporation do? Business model and key facts

Get the full picture of National Research Corporation: what it builds, where it operates, and how it makes money.

National Research Corporation Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 368

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

shop
Company facts
Trent Green
CEO
368
Employees worldwide
shop
Performance
8.65%
Last 12 months
-56.4%
Last 5 years
shop
Growth
$143,06M
Revenue year
$24,78M
Net income
shop
Valuation
$461,08M
Market Cap
16.88
Price/Earnings Ratio

Stocks related to National Research Corporation

Selected based on industry alignment and relative market positioning.

HSTM
HealthStream, Inc.
21.59
-0.46%
6.3
Sell
Buy
HealthStream, Inc.
PHR
Phreesia, Inc.
14.90
-1.88%
6.9
Sell
Buy
Phreesia, Inc.
SDGR
Schrödinger, Inc.
14.77
-0.75%
9.1
Sell
Buy
Schrödinger, Inc.
CTEV
Claritev Corporation
27.61
+2.11%
8.5
Sell
Buy
Claritev Corporation
SY
So-Young International Inc.
3.01
-1.15%
10.0
Sell
Buy
So-Young International Inc.

National Research Corporation fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.